ALUPENT LIQ 50MG/ML
ALUPENT LIQ 50MG/ML
Discontinued
DIN Number
00003859
Drug Class
Human
Market Date
Dec 31, 1970
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00003859
AIG Number0102598003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AB03 ORCIPRENALINE
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
,
Inhalation
AHFS Classification12:12.08.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
ORCIPRENALINE SULFATEActive
Strength: 50 MG / ML
Monograph: ORCIPRENALINE SULFATE